Foundation Medicine Inc (FMI):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7894)
◆英語タイトル:Foundation Medicine Inc (FMI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7894
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:70
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; FoundationACT, a blood-based circulating tumor DNA (ctDNA) assay for solid tumor; and FoundationOne CDx, a diagnostic assay for solid tumors. It also provides additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.

Foundation Medicine Inc (FMI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Foundation Medicine Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Cota Raises Funds through Venture Financing 12
Foundation Medicine Secures USD42.5 Million In Series B Financing 13
Partnerships 15
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 15
Foundation Medicine Enters into Partnership with Novartis 16
Foundation Medicine Enters into Partnership with Merck 17
Foundation Medicine, Roche and DIAN Diagnostics Enter into Partnership 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Equity Offering 30
Foundation Medicine Raises USD250 Million in Private Placement of Shares 30
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 31
Foundation Medicine Completes IPO Of Shares For US$122 Million 32
Acquisition 34
Roche to Acquire Remaining Stake in Foundation Medicine for USD2.4 Billion 34
Foundation Medicine Inc – Key Competitors 35
Foundation Medicine Inc – Key Employees 36
Foundation Medicine Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Strategy And Business Planning 38
Jun 08, 2017: ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization Study 38
Financial Announcements 39
Mar 07, 2018: Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook 39
Jan 08, 2018: Foundation Medicine Reports Preliminary 2017 Results 41
Nov 01, 2017: Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights 43
Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights 44
May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights 46
Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook 48
Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results 49
Corporate Communications 51
Jul 26, 2018: Chugai Pharmaceutical announces organizational and personnel changes 51
Oct 10, 2017: Foundation Medicine Appoints Tom Civik as Chief Commercial Officer 52
Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition 53
Legal and Regulatory 54
Jul 18, 2018: Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit 54
Nov 07, 2017: Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine 55
Government and Public Interest 56
Aug 15, 2017: Cancer Treatment Centers Of America And Foundation Medicine Join Forces to Advance Precision Cancer Treatment 56
Product News 57
May 29, 2018: Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care 57
Apr 11, 2018: Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies 63
May 18, 2017: Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling in Personalized Clinical Care in Oncology 66
Other Significant Developments 68
May 02, 2018: Foundation Medicine launches gene expression profiling program to identify known and novel biomarkers in advanced cancer 68
Jan 30, 2018: Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling 69
Appendix 70
Methodology 70
About GlobalData 70
Contact Us 70
Disclaimer 70

List of Tables
Foundation Medicine Inc, Medical Equipment, Key Facts, 2017 2
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Deals By Market, 2012 to YTD 2018 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cota Raises Funds through Venture Financing 12
Foundation Medicine Secures USD42.5 Million In Series B Financing 13
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 15
Foundation Medicine Enters into Partnership with Novartis 16
Foundation Medicine Enters into Partnership with Merck 17
Foundation Medicine, Roche and DIAN Diagnostics Enter into Partnership 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Raises USD250 Million in Private Placement of Shares 30
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 31
Foundation Medicine Completes IPO Of Shares For US$122 Million 32
Roche to Acquire Remaining Stake in Foundation Medicine for USD2.4 Billion 34
Foundation Medicine Inc, Key Competitors 35
Foundation Medicine Inc, Key Employees 36
Foundation Medicine Inc, Other Locations 37

List of Figures
Foundation Medicine Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Foundation Medicine Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Foundation Medicine Inc (FMI):医療機器:M&Aディール及び事業提携情報(Foundation Medicine Inc (FMI) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆